Post-dexamethasone cortisol as a predictor for the efficacy of electroconvulsive therapy in depressed inpatients

Journal of Psychiatric Research

Volumn 45, Issue 9, 2011, Pages 1165-1169

  Vukadin, Miljana ^a   Birkenhäger, Tom K ^a   Wierdsma, André I ^a   Groenland, Theo H N ^a   Van den Broek, Walter W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Dexamethasone suppression test; Electroconvulsive therapy; Major depression; Prediction

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE;

ADULT; AGED; ARTICLE; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; ELECTROCONVULSIVE THERAPY; FEMALE; HAMILTON SCALE; HOSPITAL PATIENT; HUMAN; HYDROCORTISONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; SCORING SYSTEM; TREATMENT OUTCOME;

ADULT; DEPRESSION; DEXAMETHASONE; ELECTROCONVULSIVE THERAPY; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; INPATIENTS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; SALIVA;

EID: 80051672671     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2011.03.012     Document Type: Article

References (24)

1. Diagnostic and statistical manual of mental disorders 1994, American Psychiatric Association, American Psychiatric Association, Washington, DC. 4th ed.
2. Bech P., Kastrup M., Rafaelsen O.J. Mini-compendium of rating scales for states of anxiety, depression, mania and schizophrenia with corresponding DSM-III syndromes. Acta Psychiatrica Scandinavica 1986, Suppl. 326:23-28.
3. Birkenhäger T.K., Pluijms E.M., Lucius S.A. ECT response in delusional versus non-delusional depressed inpatients. Journal of Affective Disorders 2003, 74:191-195.
4. Caroll B. The hypothalamic-pituitary-adrenal axis functions, control mechanisms and methods of study. Depressive illness: some research studies 1972, vol. 3:23-68. C.C. Thomas, Springfield, Ill. B. Davies, B.J. Caroll, R.M. Mowbray (Eds.).
5. Carroll B.J., Feinberg M., Greden J.F., Tarika J., Albala A.A., Hasket R.F., et al. A specific laboratory test for the diagnosis of melancholia: standardisation, validation, and clinical utility. Archives of General Psychiatry 1981, 38:15-22.
6. Fink M. Should the dexamethasone suppression test be resurrected?. Acta Psychiatrica Scandinavica 2005, 112:245-249.
7. Heijnen W.T., Birkenhäger T.K., Wierdsma A.I., van den Broek W.W. Antidepressant pharmacotherapy failure and response to subsequent electroconvulsive therapy: a meta-analysis. Journal of Clinical Psychopharmacology 2010, 30:616-619.
8. van Hemelrijck J., Weekers F., van Aken H., Bouillion R., Heijns W. Propofol anaesthesia does not inhibit stimulation of cortisol synthesis. Anesthesia & Analgesia 1995, 80:573-576.
9. Heuser I.J., Yassouridis A., Holsboer F. The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. Journal of Psychiatric Research 1994, 28:341-356.
10. Hickie I., Mason C., Parker G., Brodaty H. Prediction of ECT response: validation of a refined sign-based (CORE) system for defining melancholia. British Journal of Psychiatry 1996, 169:68-74.
11. Katona C.L., Aldridge C.R., Roth M., Hyde J. The dexamethasone suppression test and prediction of outcome in patients receiving ECT. British Journal of Psychiatry 1987, 150:315-318.
12. Kirschbaum C., Hellhammer D.H. Salivary cortisol in psychoneuroendocrine research: recent developments and applications. Psychoneuroendocrinology 1994, 19:313-333.
13. Lieb K., Rexhausen J.E., Kahl K.G., Schweiger U., Philipsen A., Hellhammer D.H., et al. Increased diurnal salivary cortisol in women with borderline personality disorder. Journal of Psychiatric Research 2004, 38:559-565.
14. Murphy B. Steroids and depression. Journal of Steroid Biochemistry and Molecular Biology 1991, 38:537-559.
15. Nelson J.C., Davis J.M. DST studies in psychotic depression: a meta-analysis. American Journal of Psychiatry 1997, 154:1497-1503.
16. Petrides G., Fink M., Husain M.M., Knapp R.G., Rush A.J., Mueller M., et al. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. Journal of ECT 2001, 17:244-253.
17. Ribeiro S.C., Tandon R., Grunhaus L., Greden J.F. The DST as a predictor of outcome in depression: a meta-analysis. American Journal of Psychiatry 1993, 150:1618-1629.
18. Spitzer R.L., Endicott J. A diagnostic interview: the schedule for affective disorders and schizophrenia. Archives of General Psychiatry 1978, 35:837-844.
19. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet 2003, 361:799-808. UK ECT ReviewGroup.
20. Vreeburg S.A., Kruijtzer B.P., van Pelt J., van Dyck R., de Rijk R.H., Hoogendijk W.J., et al. Associations between sociodemographic, sampling and health factors and various salivary cortisol indicators in a large sample without psychopathology. Psychoneuroendocrinology 2009, 34:1109-1120.
21. Vreeburg S.A., Hoogendijk W.J., van Pelt J., De Rijk R.H., Verhagen J.C., van Dyck R., et al. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study. Archives of General Psychiatry 2009, 66:617-626.
22. Young E.A., Haskett R.F., Grunhaus L., Pande A., Weinberg V.M., Watson S.J., et al. Increased evening activation of the hypothalamic-pituitary-adrenal axis in depressed patients. Archives of General Psychiatry 1994, 51:701-707.
23. Yuuki N., Ida I., Oshima A., Kumano H., Takahashi K., Fukuda M., et al. HPA axis normalization, estimated by DEX/CRH test, but less alteration on cerebral glucose metabolism in depressed patients receiving ECT after medication treatment failures. Acta Psychiatrica Scandinavica 2005, 112:257-265.
24. Zobel A.W., Nickel T., Sonntag A., Uhr M., Holsboer F., Ising M. Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression: a prospective study. Journal of Psychiatric Research 2001, 35:83-94.